Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
Featured
Page 4
Featured
Featured posts
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
BridgeBio’s BEYONTTRA approved by European Commission to treat ATTR-CM
UK unveils funding for AI companies to transform cancer care and spark new drug breakthroughs
Cancer Research UK, Cytovation and the Norwegian Cancer Society to advance...
23rd January 2025
Multi-million Euro research initiative to use biomarkers to transform Crohn’s Disease
22nd January 2025
Sarclisa approved in EU as first anti-CD38 therapy in combination with...
22nd January 2025
Glox Therapeutics awarded share of £3m Collaborative Discovery Programme funding from...
21st January 2025
Pioneer Group drives AI innovation in healthcare through industry and academic...
21st January 2025
FDA approves LUMAKRAS in combination with Vectibix for chemorefractory KRAS G12C-mutated...
20th January 2025
AstraZeneca’s Calquence plus chemoimmunotherapy approved in the US for patients with...
20th January 2025
InflaRx gains European Commission approval for GOHIBIC to treat SARS-CoV-2-induced acute...
20th January 2025
Lyndra forms strategic clinical research and commercial manufacturing services collaboration with...
17th January 2025
Formycon and Fresenius Kabi secure MHRA approval for Stelara biosimilar
17th January 2025
1
...
3
4
5
...
146
Page 4 of 146
News
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
AbbVie and Xilio Therapeutics, a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, have announced a collaboration and...
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
14th February 2025
The Duchenne muscular dystrophy (DMD) market across the seven major markets (7MM*) is set to grow from $2.3 billion in 2023 to $5.2 billion...
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
13th February 2025
Royalty Pharma has entered into an agreement with Biogen to provide research and development (R&D) funding of up to $250 million for litifilimab, a...